Document is current

Any future updates will be listed below

Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways

Crossref DOI link: https://doi.org/10.1136/lupus-2020-000424

Published Online: 2020-10-09

Published Print: 2020-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark